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Abstracts
Introduction: Myocardial infarction is caused by the obstruction of an artery in
places of atherosclerosis plaque rupture. Endothelial cells during their activation
express chemoattractant and adhesion molecules whereas infiltrating
inflammatory cells produce enzymes, predisposing a lesion to rupture.
Material and methods: We investigated the correlation between polymorphisms
in the human genes E-selectin (Ser128Arg), ICAM1 (K469E), OLR1 (K167N), MMP1
(1G/2G) and MMP3 (-1612 5A/6A) and the risk of MI in young Poles under 45
years. There was no significant difference in the frequency of single nucleotide
polymorphism (SNP) of the studied genes E-selectin (Ser128Arg), ICAM1 (K469E),
OLR1 (K167N) and MMP3 (–1612 5A/6A) between patients with MI and controls.
Results: The analysis of the association of the 1G2G polymorphism with the risk
of myocardial infarction indicated an odds ratio (OR) of 5.68 (95% confidence
interval [95% CI] 2.60 to 12.36). Other factors associated with myocardial
infarction were: smoking (OR 4.12; 95% CI 1.63-10.44), male sex (OR 16.02; 95% CI
5.90-43.46), hypercholesterolaemia (OR 2.74; 95% CI 1.29-5.83) and arterial
hypertension (OR 4.56; 95% CI 1.66-14.47).
Conclusions: We found that only MMP1 1G/2G polymorphism is associated with
myocardial infarction in the Polish population of individuals younger than 45
years. Clinical factors seemed to play a greater role in the analysed group.
Key words: gene polymorphism, coronary artery disease, atherosclerosis.
Introduction
Myocardial infarction (MI) is the main cause of death in Poland,
estimated at about 40% of all deaths [1]. Data from CDC (Centers for
Disease Control and Prevention) have shown that men have a significantly
higher prevalence of MI history than women (5.5 vs. 2.9%) [2].
The most important clinical risk factors for CAD (coronary artery disease)
are: arterial hypertension, smoking, hypercholesterolaemia, diabetes mellitus
and age [3-6]. Data have indicated that patients under 45 years of age
constitute approximately 10% of the whole population of subjects with
myocardial infarction [2, 7]. Furthermore, studies conducted on monozygotic
twins have shown the role of genetic factors in mortality due to coronary
heart disease at different ages, among both women and men [8-10].
Approximately 90% of all cases of myocardial infarction are the result
of acute thrombus causing obstruction of an artery in places of
atherosclerosis plaque rupture [1, 11-13]. 
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Arteriogenesis requires an inflammatory process
which is started by endothelial dysfunction and its
activation [14]. This activation is related to increased
expression of chemoattractant cytokines and
adhesion molecules (E-selectin, ICAM1, VCAM). 
E-selectin and ICAM1 play an important role in the
rolling of leukocytes on activated endothelial cells
and may also participate in the transition to stable
adhesion that precedes transmigration [15, 16].
Amino acid change from serine (S) to arginine (R) in
codon 128 (S128R) in the EGF (amino-terminal lectin-
like) domain of the E-selectin gene changes the
protein structure, as well as its function [17]. Yoshida
et al. found that Ser128Arg mutation of E-selectin
significantly enhanced its adhesion to leukocytes
under physiological flow conditions, which may play
a role in the development of atherosclerosis [15]. 
Intercellular adhesion molecule-1 (ICAM1) is related
to the adhesion of circulating leukocytes to the
activated endothelium. The K469E polymorphism
represents a change of amino acid, which occurs in Ig
domain 5. E469 increases the adhesion of circulating
leukocytes to the activated endothelium, which is
related to the development of atherosclerosis [16].
The production of leukocyte binding molecules 
(E-selectin, ICAM1) is induced by oxidized LDL bound
with their receptor ORL-1 on the surface of the
endothelium [18]. The G501C genotype of the OLR1 gene
which resulted in the missense mutation of K167N in
the extracellular ligand-binding domain of the LOX-1
protein may affect the binding affinity between Ox-LDL
and LOX-1. Tatsuguchi et al. and Hattori et al. found that
carriers of the C allele have higher risk of MI or CAD than
GG homozygotes [18, 19].
The mechanism leads to the recruitment and
adhesion of inflammatory cells to the endothelium.
Migration of the monocytes and their transformation
into macrophages leads to the increased expression
of scavenger receptors on their surface. Macrophages
use them to bind modified LDL and transform
themselves into foam cells, which are the main
component of an atherosclerotic lesion. Apart from
foam cells, the lesions contain numerous other
inflammatory cells, smooth muscle cells and the
extracellular matrix (collagen, elastin and
proteoglycans). Macrophages and smooth muscle
cells produce the metalloproteinases (MMPs). MMPs,
particularly MMP1, MMP2, MMP3 and MMP9, are
involved in the degradation of extracellular matrix,
resulting in weakening of the fibrous cap and the
subsequent destabilization of atherosclerotic lesions
[20-22]. MMP1 can degrade collagens type I and III
and its expression significantly increases in
atherosclerotic plaque characterized by having a thin
fibrous cap [23]. The MMP1 GG/GG polymorphism is
associated with enhanced translation into functional
MMP1 [24], so we postulated that this polymorphism
can promote atherosclerotic plaque rupture. 
MMP3 has a broad substrate spectrum, which
includes most major constituents of the arterial wall,
such as fibronectin, type IV, V, IX, and X collagens,
gelatin, laminins, elastin, and proteoglycan proteins
[21]. The 5A/6A polymorphism in the promoter has
been shown to have an effect on MMP3 expression.
The 5A allele is related to higher transcriptional
activity than 6A [25]. Some studies have found that
5A/5A homozygotes have significantly higher risk
of MI than non-carriers [26, 27].
Recently, we have examined the relation
between the polymorphism of human genes 
E-selectin (Ser128Arg), ICAM1 (K469E), OLR1
(K167N), MMP1 (1G/2G) and MMP3 (-1612 5A/6A)
and the risk of MI in young Poles aged 45 years or
less.
Material and method
Study population
Blood samples were collected from 163 unrelated
patients with myocardial infarction in whom the first
incident of MI occurred before 45 years of age. All
subjects were white Caucasians and showed no
typical symptoms of CAD before the first incident of
MI. Myocardial infarction was confirmed by chest
pain associated with specific ischaemic ECG changes,
high serum troponin (T or I) and increased CKMB
activity. All participants reported having undergone
coronary angiography during their first hospitalization
to determine the level of atherosclerotic lesion
progression. The coronary segments (right coronary
artery: proximal, middle, distal; left main coronary
artery; left anterior descending artery; two segments
of diagonal branches, left circumflex artery and
marginal branches), identified visually as abnormal,
were measured quantitatively.
The control group consisted of 140 unrelated,
asymptomatic, apparently healthy subjects. The
inclusion criteria for the control group were set as
follows: age > 45 years, no symptoms of CAD and
a SCORE index below 4%. The SCORE (Systematic
Coronary Risk Evaluation) and the SCORECARD
allow the estimation of fatal coronary risk in
asymptomatic, apparently healthy subjects. Those
who are at 4% and lower have low risk of
developing fatal cardiovascular events [28]. Arterial
hypertension according to WHO/ISH criteria [29],
hypercholeste  ro  laemia (elevated total serum
cholesterol levels > 200 mg/dl) and the habit of
smoking were not exclusion criteria. 
All controls without symptoms of CAD were
recruited from the same geographical region as the
patients. 
Patients and controls with diabetes mellitus were
not enrolled in the study. We also collected
information about positive MI or CAD family history
of the first degree, smoking habit and blood pressure
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(with respect to patients all information was related
to the period before the first CAD incidence).
The Institutional Ethics Committee has approved
of the study protocol and the size of samples. All
participants were obliged to sign an informed
consent form prior to enrolment in the study. 
Genotype determination
Venous blood from all individuals in the study
was collected into vials containing 3.2% sodium
citrate. The samples were stored frozen at –20°C
until the extraction of DNA. Genomic DNA was
extracted from blood leukocytes using standard
methods (phenol/chloroform). 
The samples of 100 ng genomic DNA template and
50 pM of each primer were used in the polymerase
chain reaction (PCR). Denaturation was performed at
94°C for 60 s and annealing at 55-60°C for 60 s, with
extension at 72°C for 45 s with a 30-cycle
amplification. DNA amplification was followed by
restriction enzymes digestion and agarose gel
electrophoresis (restriction fragment length
polymorphism – RFLP). Primers for all examined
polymorphic sites are presented in Table I.
Statistical analysis
Age was expressed as median and interquartile
range (IQR) due to non-normal distribution. Nominal
data were expressed as percentages or fractions.
Frequency of alleles was tested against the Hardy-
Weinberg equilibrium. The Pearson χ2, Yates
corrected χ2 or Fisher exact test was used for data
comparisons depending on the number of cases.
Logistic regression analysis was performed to
determine the association of particular factors with
the incidence of a myocardial infarct prior to 
45 years of age. Univariate comparisons were
performed for all analysed factors, and the factors 
with  p values < 0.15 were entered into
a multi  variate backward, stepwise model. A p value
of < 0.05 was deemed as statistically significant in
multivariate analysis. Statistica 7.0 and MedCalc 8.0
statistical packages were used for all computations.
Results
During the study period, a group of 163 eligible
patients and 140 controls were enrolled. The
analysed clinical factors such as hypertension,
hypercholesterolaemia and smoking (past or active)
were more frequent in the study group than in the
controls. In our research we had individuals with 
a past or active smoking habit. However, in the
control group only 2 out of 82 smokers were past
smokers. The study group consisted of 142 past or
active smokers, 75 of whom were past smokers but
they stopped smoking only after the first incident
of myocardial infarction. Due to this fact we did not
separate smokers into two groups of past and
active ones. The patients in the study group were
younger than the controls and in the MI group there
were more males compared with healthy
participants (83.4 vs. 47.1%). Detailed characteristics
of the studied groups are presented in Table II.
Gene SNP Primers Restriction enzyme Reference
E-selectin Ser128Arg For  5’-ATGGCACTCTGTAGGACTGCT-3' PstI Ye et al. (1999) [30]
Rev 5’-GTCTCAGCTCACGATCACCAT-3'
ICAM1 K469E For 5’ AGGATGGCACTTTCCCACT- 3’ BstUI Yokoyama et al. (2005) [14] 
Rev 5’ GGCTCACTCACAGAGCACAT- 3’
OLR1 K167N For 5’-GGCTCATTTAACTGGGAAAG-3’ NlaIV Trabetti et al. (2006) [31]
Rev 5’-CCGTCCAAGGTCATACACAA-3’
MMP1 –1607 1G/2G For 5’-TCGTGAGAATGTCTTCCCATT-3’ XmnI Dunleavey et al. (2000) 
Rev 5’-TCTTGGATTGATTTGAGATAAGT [32]
GAAATC-3’
MMP3 –1612 5A/6A For 5’- CTTCCTGGAATTCACATCACT GCCACCACT -3’
Rev 5’-GGTTCTCCATTCCTTTGATGG GGGGAAAGA – 5’ Tth11I Agostino et al. (2000) [33]
Table I. Primers and restriction enzymes used for the detection of the sequence variants
Characteristic Study group Control groupV alue of p
Age 41 ±4.9 54 ±8.6 < 0.0001
Male sex (fraction and %) 136/163 (83.4%) 66/140 (47.1%) < 0.001
Smokers (fraction and %) 142/163 (87.1%) 82/140 (58.6%) < 0.001
Arterial hypertension (fraction and %) 62/163 (38%) 21/140 (15.0%) < 0.001
Hypercholesterolaemia (fraction and %) 93/151 (57.1%) 44/140 (31.4%) < 0.001
Table II. Detailed characteristics of the studied population
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Full genetic screening of E-selectin, ICAM1, OLR1,
MMP1 and MMP3 genes was performed in 276, 291,
280, 216 and 235 participants (study and control)
respectively. The discrepancy between the results
of genetic screening for both groups results from
the impossibility of obtaining satisfactory quality
findings of some samples. The frequency of 
E-selectin, ICAM1, OLR1, MMP1 and MMP3 alleles
and genotypes is given in Table III.
The genotypes represent homozygotes of the
more frequent allele (A/A), heterozygotes (A/a) and
minor allele homozygotes (a/a). All values are given
as Ns. (H-W E – Hardy-Weinberg equilibrium, 
a p < 0.05 suggests non-random distribution of
alleles in the group.)
No statistically significant difference was
observed in genotype frequencies for E-selectin,
ICAM1, OLR1 and MMP3 polymorphisms in the
study and the control group. The genotype
distribution of the E-selectin (A561C → Ser128Arg)
polymorphism was: AC + CC 28.3% for the study
group vs. 25% for the controls. For ICAM1 (K468E)
the percentage of patients who had either KE or EE
genotypes was 66.3 vs. 63.4% for the controls. For
OLR1 (K167N) the distribution of genotypes was as
follows: KN + NN 14.3% for the study group vs.
16.5% for the controls. For MMP3 (–1612 5A/6A) it
was 5A/6A + 6A/6A 37.1% for the MI group vs.
35.3% for the controls. Comparisons of minor allele
carriage frequencies are presented in Table IV.
The frequency of MMP1 alleles deviated
significantly from values expected from the Hardy-
Weinberg equilibrium. Only the MMP1 GG allele
carriage differed in frequency between the
compared groups. The results for univariate and
multivariate analysis of the GG allele in MMP1 were
OR 3.6995, 95% CI 2.1026-6.5062, p = 0.001 and OR
5.6751, 95% CI 2.6035-12.3609, p = 0.0001,
respectively. Tables V and VI show the results of
univariate and multivariate logistic regression
analyses. The carriage of the GG allele in MMP1 was
the only evaluated genetic factor associated with
the incidence of myocardial infarct, and showed
significantly increased risk of MI. We did not
consider age in the univariate and multivariate
logistic regression because in our study age is not
a risk factor of MI but it is a criterion of group
selection.
The following analysed clinical factors increased
the risk of early myocardial infarction: male sex (OR
16.02; 95% CI 5.90-43.46), smoking habit (OR 4.12;
95% CI 1.63-10.44), arterial hypertension (OR 4.56;
95% CI 1.66-14.47) and hypercholesterolaemia (OR
2.74; 95% CI 1.29-5.83).
Discussion
The aim of this study was to investigate
functional polymorphisms in the genes related to
atherosclerosis to elucidate their impact on
myocardial infarction in young Poles under 45 years
of age. The polymorphism association study was
related to 5 different genes: E-selectin (Ser128Arg),
ICAM1 (K469E), OLR1 (K167N), MMP1 (–1607 1G/2G)
and MMP3 (–1612 5A/6A). Previous studies have
shown that these polymorphisms are implicated in
Gene Minor allele frequency A/A A/aa /a P value of H-W E testing
E-selectin 14.3%  128Arg 102 29 5 0.12
(Ser128Arg) (Ser/Ser) (Ser/Arg) (Arg/Arg)
ICAM1 37.0% 469E 48 69 14 0.14
(K469E) (K/K) (K/E) (E/E)
OLR1 8.9% 167N 106 20 1 0.97
(K167N) (K/K) K/N (N/N)
MMP1 35.2% (–1607 1G) 41 61 6 0.001
(–16071G/2G) (2G/2G) (1G/2G) (1G/1G)
MMP3 19.3% (–1612 5A) 77  38 4 0.79
(–1612 5A/6A) (6A/6A) (5A/6A) (5A/5A)
Table III. Frequencies of particular alleles and genotypes in the control group
Gene Study group Control groupV alue of p
E-selectin 46/162 (28.3%) 34/136 (25%) 0.59
ICAM1 106/160 (66.3%) 83/131 (63.4%) 0.63
OLR1 22/153 (14.3%) 21/127 (16.5%) 0.62
MMP1 33/98 (33.7%) 77/118 (65.3%) < 0.001
MMP3 43/116 (37.1%) 42/119 (35.3%) 0.78
Table IV. Minor allele carriage frequencies in cases and controlsthe invasion of the vascular wall by inflammatory
cells and in atherosclerotic plaque formation and
rupture [14, 30, 34]. Furthermore, some groups of
researchers have found a relation between these
polymorphisms and increased risk of CAD or MI [16,
18, 30]. For these reasons, we wanted to check
whether these polymorphisms may have an impact
on myocardial infarction in the Polish population.
E-selectin (CD62E) is strongly expressed on the
endothelial cell after its activation. It mediates the
rolling of leukocytes on endothelial cells [35, 36].
This process contributes to vascular disease 
such as acute or chronic inflammation and
atherosclerosis [35]. Four domains have been
identified in the selectin family: amino-terminal
lectin-like domain, epidermal growth factor (EGF)-
like domain, transmembrane domain and a short
cytoplasmic domain [35]. The common Ser128Arg
polymorphism has been reported in the EGF domain
of the E-selectin gene [35, 36]. It alters the binding
specificity of E-selectin and enhances the
interaction between inflammatory cells and
endothelium. A recent study demonstrated that this
polymorphism can influence the regulation of
plasma levels of sE-selectin [36].
Ye et al. showed a relation between Ser128Arg
polymorphism and CAD in the Caucasian population
[30]. According to Li Yan et al., the frequency of the
128Arg allele was higher among CAD patients
compared to the controls (6.7 vs. 3.1%) [37].
Moreover, another group of researchers has
reported an association of this polymorphism with
myocardial infarction in Japanese patients [35]. We
did not confirm the latter relation, probably due to
different ethnic and genetic backgrounds of studied
subjects.
Many studies have shown an association
between K469E polymorphism of the ICAM1 (CD54)
gene and CAD or atherosclerosis [16, 38, 39]. This
molecule is engaged in binding and interacting with
leukocyte integrin receptors and thus leads to the
attachment of leukocytes to endothelial cells. This
process is required for the transendothelial
migration of leukocytes into the vascular wall [16].
ICAM1 has been found on macrophages, fibroblasts,
circulating leukocytes and on the surface of
endothelial cells or smooth muscle cells in
atherosclerotic plaques [14, 16]. A single nucleotide
polymorphism C/T of the gene ICAM1 that results
in substitution of lysine (K) by glutamic acid (E) in
the ICAM1 protein alters the normal structure of
ICAM1 protein and thus leads to different
interactions of ICAM1 with its ligands [16]. In their
study, Jiang and associates reported that the allele
distribution of the ICAM1 K 469 allele was
significantly increased in German patients with CAD
and MI [16]. A high correlation between K469
genotype and plasma fibrinogen or early
atherosclerotic change was found by Yokoyama et
al. [14]. The ICAM1 K469E polymorphism is related
to stroke [40] and Graves disease [41]. In contrast
to previously described studies, we found no
Variable Odds ratio 95% CI Value of p
Scavenger receptor N allele carrier 0.8477 0.4423-1.6246 0.61
E-selectin C allele carrier 1.1897 0.7094-1.9950 0.51
MMP1 GG carrier 3.6995 2.1026-6.5062 0.001
MMP3 5A allele carrier 1.0799 0.6342-1.8389 0.78
ICAM1 E allele carrier 1.1352 0.7000-1.8409 0.61
Arterial hypertension 3.4785 1.9841-6.0986 0.0001
Male sex 4.9853 2.9893-8.3142 0.0001
Smoking habit 4.3669 2.5089-7.6010 0.0001
Cholesterol > 200 mg/dl 3.4984 2.1548-5.6800 0.0001
Table V. Univariate logistic regression results of factors tested for association with myocardial infarction under 
45 years of age (95%CI – 95% confidence interval)
Variable Odds ratio 95% CI Value of p
Smoking habit 4.1252 1.6306-10.4367 0.003
Gender 16.0168 5.9029-43.4598 0.0001
Hypertension 4.5557 1.6643-12.4705 0.003
Cholesterol > 200 2.7413 1.2891-5.8298 0.009
MMP1 GG carrier 5.6754 2.6035-12.3609 0.0001
Table VI. Multivariate logistic regression results of factors tested for association with myocardial infarct under 
45 years of age (95% CI – 95% confidence interval)
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correlation between MI and ICAM1 K469E
polymorphism and our results are in agreement
with the study of Sarecka-Hujar et al. [42].
According to Sarecka-Hujar et al., Polish carriers of
one ICAM1 K469E polymorphism have no higher
risk of MI but triple combinations among C677T
MTHFR, K469E ICAM1 and G174C IL-6 poly  -
morphisms increased the risk of CAD [42].
In the pathogenesis of cardiovascular disease
and atherosclerosis, the main role is played by
oxyLDL and their accumulation within blood vessel
walls [43]. Many studies have indicated that oxyLDL
induces endothelial dysfunction and leads to its
activation [18, 44, 45]. This activation is related to
expression of the scavenger receptor LOX1 (or OLR1)
on endothelial cells. OxyLDL binding to the receptor
stimulates endothelial cells to produce leukocyte
adhesion molecules, chemokines, endothelin-1 and
the superoxide anion [18, 43]. OLR1 can also bind
red blood cells, apoptotic cells and activated
platelets [18, 46]. OLR1 has not only been found on
endothelial cells but is also expressed in
macrophages, vascular smooth muscle cells (SMC),
monocytes, cultured rat and human chondrocytes,
and human INT-407 intestinal cells [18, 44].
Macrophages use the scavenger receptor to bind
modified LDL and to transform themselves into
foam cells, which form the main component of the
atherosclerotic lesion [44]. In the OLR1 gene 
a G501C single nucleotide polymorphism was found
by Tatsuguchi et al. [5, 18]. This polymorphism leads
to the missense mutation of K167N, which is
located at the C-type lectin-like domain in the
extracellular portion of OLR1. This polymorphism
may affect the affinity of interaction between Ox-
LDL and OLR1 [19]. Some studies have pointed to 
a significant association of the 501C genotype of
OLR1 with the risk of coronary artery disease or MI
[5, 18, 19, 44, 47]. According to Tatsuguchi et al.,
carriers of the C501 allele have significantly higher
predisposition to MI 2.89 (95%CI 1.51-5.53) than GG
homozygotes [18]. But Ohomori et al. and Trabetti et
al. failed to show any relation between G501C
genotype and acute myocardial infarction [48, 49].
Their observations were confirmed in the present
study. This discrepancy may be related to a different
genetic background in the population studied, or to
the different selection of patients and healthy
controls.
Our results show a relation between matrix
metalloproteinase-1 promoter polymorphism and
higher risk of MI in young Poles. This study showed
that carriers of the GG (2G) allele have higher risk of
MI than 1G homozygotes. We believe that a higher
level of MMP1 can contribute to plaque instability.
Nikkari et al. found that in human carotid arteries,
MMP1 is expressed in advanced atherosclerotic
plaques and this enzyme contributes to plaque
expansion, disruption and thrombosis [22]. MMP1 is
the major collagenase that can cleave native collagen
types I and III, components of the fibrous plaque cap
[50]. MMP1 expression is significantly increased in
atherosclerotic plaque which is characterized by 
a thin fibrous cap and a large lipid core. Studies have
shown that carriers of –1607 insertion of G nucleotide
(2G homozygotes) have over 20-fold higher
transcriptional activity of MMP1 compared with 1G
homozygotes. Rutter et al. have reported that 1G/2G
polymorphism has an influence on binding of an Ets1
transcription factor by the creation of a core binding
site for this factor [51].
Many researchers have suggested a positive
correlation between increased MMP1 expression
and atherosclerotic plaque rupture, which is the
main cause of myocardial infarction [23, 25, 52].
Martin et al. reported a statistically significant
association between carriers of the 2G poly  -
morphism and increased risk of remodelling after
MI [24].
The genetic data indicated that the MMP1 gene
1G/2G variations are strong candidates for coronary
artery disease [50, 53]. Furthermore, Noijri et al.
have found that 1G/2G MMP1 and 5A/6A MMP3
polymorphisms are in strong linkage disequilibrium
and that the 5A-1G haplotype is associated with MI
in Japanese [52].
MMP3 metalloproteinase possesses proteolytic
activity on II, IV, and IX collagen, proteoglycans,
laminin, fibronectin, gelatins and elastin [25]. The
–1612 5A/6A polymorphism has an effect on MMP3
expression. Individuals with the 5A allele have
higher gene expression than those with the 6A
allele. This difference is related to different affinity
for transcriptional repressor p50/p50. The higher
promoter activity is the result of reduced binding
of the transcriptional repressor [25, 54]. Thus the
6A allele is related to increased matrix protein
deposition around an atherosclerotic lesion,
whereas the 5A allele is associated with increased
matrix degradation [11, 52]. Many studies have
reported that 5A/5A homozygotes have higher
predisposition to myocardial infarction [27, 52, 54].
According to Beyzade et al. and Terashima et al.,
carriers of the 5A allele have 1.5-2.0-fold higher risk
of MI than non-carriers [27, 54]. However, our
observations did not confirm this relation. The
discrepancy could be due to the differences
between the population groups and the
environmental exposures. 
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